Brazil’s daily death toll from COVID exceeds 4,000 for the first time

Refinery 29

The COVID-19 vaccine may have some surprising benefits

Hours before the first COVID-19 vaccine was approved for emergency use in the United States, I called epidemiologists and healthcare professionals to elaborate on the expected benefits of widespread vaccination. Thanks to COVID-19, the hospital is not overwhelmed. The people I spoke to called the news the moment of “light at the end of the tunnel.” Shooting in as many arms as possible would be the key to achieving herd immunity, they said, so we were finally able to return to some of the pre-pandemic normal resemblance. However, the three approved U.S. vaccines (Pfizer / BioNTech, Moderna, Johnson & Johnson) have been rolled out to more than 100 million Americans, which could have unexpected benefits to vaccination over what experts initially saw. I found out that there is. Here are just a few of them. Many vaccines provide at least some protection against mutants With rapid vaccine deployment, the future looks brighter than for some time, but at least one ominous cloud hangs above us. The COVID-19 mutant is a mutant strain SARS-CoV-2 virus. Experts say it is more contagious than the original strain and can be fatal. You’ve probably heard of the B.1.1.7, B.1.351, and P.1 variants that hit the UK, Brazil, and South Africa, respectively. When these strains were first identified, experts were uncertain whether existing vaccines would prevent them. Fortunately, studies have shown that both messenger ribonucleic acid (mRNA) vaccines (Pfizer and Moderna) are highly effective against the B.1.1.7 variant. These vaccines are 4-7 times less effective against the P.1 variant, but especially after two doses, the director of the National Institute of Allergy and Infectious Diseases, Anthony Fauci, MD, provided a “protective cushion”. May be provided. Said at a press conference at the White House. Early studies pointed out the idea that both the mRNA vaccine and Johnson & Johnson were less effective against the B.1.351 mutant. However, earlier this month, Pfizer released test data showing that the vaccine is 100% effective in preventing COVID-19 in South Africa, where B.1.351 is common. To be on the safe side, the developers of all three US-approved vaccines are working quickly to create more effective formulations for their mutants and are experimenting with booster shots. PreetiN, Chief Health Officer at the University of Michigan. Malani, MD, said: “I’m optimistic, but I still need to be careful.” Some COVID-19 long horrors say the vaccine relieves symptoms. The National Institutes of Health states that 10% to 30% of people infected with COVID-19 experience long-term symptoms. Some people who have dealt with the protracted problem now say that the vaccine helped relieve their symptoms. Daniel Griffin, MD, and PhD, who are responsible for ProHealth’s infections, told CNN: “They report that after vaccination, they have shown a significant, if not complete, solution to their long COVID symptoms.” A survey of 345 people, most of whom were women living in the UK. ) Reported that prolonged COVID symptoms improved more than 2 weeks after the first vaccination. Other researchers have investigated this, but no peer-reviewed research on this topic has been published. It’s too early to say why vaccines relieve long-term symptoms. Prolonged problems can occur in people who are unable to completely remove the virus from their bodies. Vaccines may stimulate a strong response from the immune system to completely eliminate the virus that causes COVID-19. Long COVID symptoms can also be caused by certain types of immune dysfunction. Vaccines may promote an “immune reset” that solves the problem, Dr. Marani explains. “We still don’t understand why some people are at risk. [long COVID]”But the fact that we’ve even heard anecdotes from people that their symptoms have alleviated after the vaccine was promising,” she adds. COVID-19 shots pave the way for future vaccine research. In 1796, a British doctor “created the first vaccine for smallpox when a patient was injected with pus from the pain of a milkmaid infected with a biologically related virus from a cow.” The University Association states. Until 2020, similar methods were used for all vaccines (except pus). Patients frequently received inactivated or weakened versions of the virus itself. However, what scientists have learned during the development of the mRNA COVID-19 vaccine may pave the way for future vaccines, including diseases such as HIV, influenza, Zika fever and rabies. (Human trials of mRNA vaccines for these diseases were already underway prior to COVID-19, an analysis of Naturenotes). Unlike other vaccines, mRNA vaccines work by instructing cells to make proteins or protein fragments that help our body recognize important parts of the virus and create an immune response against it. To do. “Thanks to COVID-19, the field of vaccines has changed forever and has progressed forever,” Dr. Dan Barouch, MD, director of the Center for Virology and Vaccine Research, Harvard Medical School, told AAMC. Pregnant people may pass immunity to newborns Vaccine trials did not include pregnant people for ethical reasons, but so far more than 69,000 pregnant people in the United States Being vaccinated, early studies suggest that the vaccine is likely to be safe and effective during pregnancy. Needless to say, preliminary findings from the American Journal of Obstetrics and Gynecology also show that if a pregnant person is vaccinated with expectations, it may also have a protective effect on newborns. This is based on other studies showing that vaccinated people may pass antibodies against COVID-19 from the placenta to the foetation. Further research is needed to confirm these findings, but if that is true, some newborns are more vulnerable to serious illness and the vaccine will soon be approved for this age group. It’s unlikely, so that’s big news. Vaccination can reduce the infectivity of people In most cases, the COVID-19 vaccine prevents people from becoming infected with the virus in the first place. However, in the rare case of someone testing positive after a jab, Israeli studies suggest that their viral load is likely to be much lower than that of unvaccinated people (a fair warning is). Not yet peer-reviewed). Low viral load (referring to the amount of virus detected on someone’s system) has two advantages. The risk of severe illness is reduced and the virus may not easily spread to others. Vaccines can reduce anxiety about COVID Sure, we knew that vaccination could be reassuring, but many said they didn’t expect to feel much better after the injection. I will. “Last year, people were afraid to do normal things like meeting friends and family, and they were really lonely,” says Dr. Marani. “Isolation and loneliness are also a major health risk, and they can make physical sacrifices to both young and older adults.” For some, vaccination If you let go of your COVID anxiety, you will feel like taking a deep breath of fresh air for the first time in a year. “After the second shot, there was a moment of“ aha ”that things were looked up and we were heading towards the new normal, whatever the new normal,” says New Yorker Alexa Nikifollow. “Did you have the hope you’re seeing? What’s a little better about R29 here? 9 Common vaccine myths, what if you get two different vaccines that have been uncovered?” Vaccine passport is coming

Posted on